Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Identifying Brain Age–Based Subtypes of Major Depressive Disorder
FY 2025-26
Summary
The brain ages differently for each person, and how your brain ages may tell more about your health risks than just your age. Major Depressive Disorder (MDD) is a common mental disorder that affects 8% of all Canadian adults annually and may accelerate brain aging. Accelerated brain aging in MDD is thought to worsen cognitive functions like memory and decision-making, and lead to certain depression symptoms like suicidal thoughts. However, only one-third of MDD patients improve after first treatment, and we cannot predict how an individual will respond. By identifying how aging impacts the brain response to various treatments, this research may pave the way for personalized treatment approaches.
Studies of brain aging in MDD have produced mixed findings: some report abnormally accelerated brain aging, while others do not. Moreover, the relationship between brain aging and response to antidepressant treatment is also unclear, with conflicting results. Two major challenges hinder our understanding of brain aging. First, while we know which specific areas of the brain are associated with brain age, we do not know which areas show signs of accelerated aging in MDD. Second, MDD symptoms vary widely among individuals. Prior studies often group all patients with MDD together, potentially masking important findings.
To address these challenges, we will use brain-age prediction algorithms on brain images from 6,400 MDD patients and healthy individuals. We will pinpoint regions associated with accelerated aging, link it to specific symptom profiles, and evaluate whether combined symptom and brain-aging patterns define treatment-relevant subtypes for MDD. Overall, this study is an exciting opportunity that will improve our understanding of how brain aging affects MDD symptoms.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572618
Name
Lim Jino
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying Brain Age–Based Subtypes of Major Depressive Disorder
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Brain Aging; Major Depressive Disorder; Psychiatric Disorders; Structural Magnetic Resonance Imaging; Subtyping Analysis; Symptom Dimensions; Treatment Response
Abstract
The brain ages differently for each person, and how your brain ages may tell more about your health risks than just your age. Major Depressive Disorder (MDD) is a common mental disorder that affects 8% of all Canadian adults annually and may accelerate brain aging. Accelerated brain aging in MDD is thought to worsen cognitive functions like memory and decision-making, and lead to certain depression symptoms like suicidal thoughts. However, only one-third of MDD patients improve after first treatment, and we cannot predict how an individual will respond. By identifying how aging impacts the brain response to various treatments, this research may pave the way for personalized treatment approaches.
Studies of brain aging in MDD have produced mixed findings: some report abnormally accelerated brain aging, while others do not. Moreover, the relationship between brain aging and response to antidepressant treatment is also unclear, with conflicting results. Two major challenges hinder our understanding of brain aging. First, while we know which specific areas of the brain are associated with brain age, we do not know which areas show signs of accelerated aging in MDD. Second, MDD symptoms vary widely among individuals. Prior studies often group all patients with MDD together, potentially masking important findings.
To address these challenges, we will use brain-age prediction algorithms on brain images from 6,400 MDD patients and healthy individuals. We will pinpoint regions associated with accelerated aging, link it to specific symptom profiles, and evaluate whether combined symptom and brain-aging patterns define treatment-relevant subtypes for MDD. Overall, this study is an exciting opportunity that will improve our understanding of how brain aging affects MDD symptoms.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lim, Jino
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~